Proprietary product developed and manufactured by Cerbe Inc., Canada, 714X is used to prevent and treat cancer, AIDS, lupus, fibromyalgia, and chronic fatigue syndrome. It is promoted as a sterile, isotonic formulation that contains nitrates (~5%), ammonium (~1.4%), and camphor (0.01%) (1). It is not legal in the United States and is available only in Canada under the Compassionate Use Program (2). 714X is injected intralymphatically in the groin area daily for 21 days followed by three treatment-free days. This cycle is repeated at least three times. Inhalation therapy is used concomitantly for patients with head and neck or lung cancer. Injection site reactions, including redness and soreness, may occur (1) (2).
No published data evaluate 714X for any of the proposed claims.
- Water (94%)
- Camphor (~<0.01%)
- Nitrate (~5%)
- Ammonium (~1.4%)
- Sodium chloride (~1%)
- Ethanol (~1%)
- Trace elements (insignificant amounts)
Mechanism of Action
Developed by Gaston Naessens, 714X is said to help disease regression, revitalize the immune system, and support host defense mechanisms. Promoters claim that the camphor has selective affinity for cancer cells, while the nitrate component fulfills cancer cells' nitrogen requirement, thereby protecting immune cells. The nitrogen-enriched camphor supposedly antagonizes the secretion of co-cancerogenic K factor (CKF) by cancer cells (1) (2). No data in the literature support the proposed mechanisms of action or benefits.
Common: Injection site reactions, such as redness, inflammation, and soreness
Literature Summary and Critique
No published clinical trials, case reports, or in vitro data support the use of 714X for any of the proposed claims.
Dosage (Inside MSKCC Only)
This field is only visible to only Inside MSKCC users.